NIDA Neuroscience Update, January 21, 2011
20 views
Skip to first unread message
Rick Bevins
Jan 22, 2011, 2:22:49 PM1/22/11
to Nebraska Substance Abuse Research Cluster
From: NIDA Neuro Science Interest Group [mailto:NIDA_NEURO_SCIENCE-
L...@LIST.NIH.GOV] On Behalf Of NIDA NEURO SCIENCE (NIH/NIDA)
Sent: Friday, January 21, 2011 8:53 PM
To: NIDA_NEURO...@LIST.NIH.GOV
Subject: NIDA Neuroscience Update, January 21, 2011
Table of Contents
I. The Study of Tobacco in Minority Populations (STOMP) Genetics
Consortium Seeks Additional Collaborators for meta-analyses of GWAS
data for smoking behavior among African-Americans
II. RFA-DA-11-012 Exploring Human Induced Pluripotent Stem Cells for
Substance Abuse Research (R21)
III. PAR-11-099 U.S. - India Bilateral Brain Research
Collaborative Partnerships (U.S. - India BRCP) (R21)
--------
I. The Study of Tobacco in Minority Populations (STOMP) Genetics
Consortium Seeks Additional Collaborators for meta-analyses of GWAS
data for smoking behavior among African-Americans.
The Study of Tobacco in Minority Populations (STOMP) Genetics
Consortium was formed in early 2010 and consists of multiple
investigators from different studies interested in conducting meta-
analyses of GWAS data for smoking behavior among African-Americans. As
of November 2010, n=27,072 African-American participants with GWAS and
smoking data are available for analyses. The sample size represents
participants from the Women's Health Initiative, the CARe studies and
multiple NCI breast and prostate cancer studies. We are investigating
smoking initiation (ever vs. never and age at onset of smoking),
smoking heaviness (CPD) and smoking cessation (former vs. current
smokers); have devised a standard analytic plan; and ask that new
studies upload summary results to the MIT/Broad Shared Space. The
STOMP Genetics Consortium analysts will conduct the meta-analyses. The
Study of Tobacco in Minority Populations (STOMP) Genetics are actively
recruiting more studies. Investigators interested in collaborating
should contact Stacey Petruzella (petr...@mskcc.org) for more
information.
II. RFA-DA-11-012 Exploring Human Induced Pluripotent Stem Cells
for Substance Abuse Research (R21)
Participating NIH Institute: NIDA
Letter of Intent: February 28, 2011
Receipt date: March 31, 2011, by 5:00 PM local time of applicant
organization.
Purpose: This FOA solicits applications to develop and standardize
methods to generate cell types relevant to substance abuse from human
iPS cells. Cells of interest include neurons and glial cells, and
cells of other tissues, if justification and rationale are provided.
The development of standardized approaches to reprogram or induce
adult cells to become pluripotent stem cells will inform our
understanding of the pathophysiology of substance use and abuse and
may provide a novel mechanism for screening compounds for the
treatment of addiction.
III. PAR-11-099 U.S. - India Bilateral Brain Research Collaborative
Partnerships (U.S. - India BRCP) (R21)
Participating NIH Institutes: NINDS, NIMH and NIDA
Participating Indian Agency: Department of Biotechnology (DBT)
Letter of Intent Due Date: Feb 22, 2011
Application Due date: March 22, 2011
Purpose: The purpose of this program is to support the establishment
and enhancement of bilateral research collaborations between U.S. and
Indian investigators in the field of neuroscience with an emphasis on
understanding, treating and curing neurological, mental and addictive
disorders. Specific areas of research may include, but are not limited
to, studies of mechanisms underlying neurological, mental and
addictive disorders and diseases, planning for population-based
research and clinical trials, the development of infrastructures for
resource, tool and data sharing in addition to projects aimed at
advancing global health research, particularly as it relates to the
mission of the participating organizations.
The National Institute on Drug Abuse at the National Institutes of
Health is an agency of the United States Department of Health and
Human Services
TO UNSUBSCRIBE: send email to list...@list.nih.gov, Copy and paste
UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email
- You will receive a confirmation email if successful. If you have
problems contact jpol...@mail.nih.gov 301-435-1309
http://list.nih.gov/cgi-bin/wa?SUBED1=nida_neuro_science-l&A=1&X=6F4BAE4CF706755A29&Y=nidaneurosc%40mail.nih.gov&A=0
L...@LIST.NIH.GOV] On Behalf Of NIDA NEURO SCIENCE (NIH/NIDA)
Sent: Friday, January 21, 2011 8:53 PM
To: NIDA_NEURO...@LIST.NIH.GOV
Subject: NIDA Neuroscience Update, January 21, 2011
Table of Contents
I. The Study of Tobacco in Minority Populations (STOMP) Genetics
Consortium Seeks Additional Collaborators for meta-analyses of GWAS
data for smoking behavior among African-Americans
II. RFA-DA-11-012 Exploring Human Induced Pluripotent Stem Cells for
Substance Abuse Research (R21)
III. PAR-11-099 U.S. - India Bilateral Brain Research
Collaborative Partnerships (U.S. - India BRCP) (R21)
--------
I. The Study of Tobacco in Minority Populations (STOMP) Genetics
Consortium Seeks Additional Collaborators for meta-analyses of GWAS
data for smoking behavior among African-Americans.
The Study of Tobacco in Minority Populations (STOMP) Genetics
Consortium was formed in early 2010 and consists of multiple
investigators from different studies interested in conducting meta-
analyses of GWAS data for smoking behavior among African-Americans. As
of November 2010, n=27,072 African-American participants with GWAS and
smoking data are available for analyses. The sample size represents
participants from the Women's Health Initiative, the CARe studies and
multiple NCI breast and prostate cancer studies. We are investigating
smoking initiation (ever vs. never and age at onset of smoking),
smoking heaviness (CPD) and smoking cessation (former vs. current
smokers); have devised a standard analytic plan; and ask that new
studies upload summary results to the MIT/Broad Shared Space. The
STOMP Genetics Consortium analysts will conduct the meta-analyses. The
Study of Tobacco in Minority Populations (STOMP) Genetics are actively
recruiting more studies. Investigators interested in collaborating
should contact Stacey Petruzella (petr...@mskcc.org) for more
information.
II. RFA-DA-11-012 Exploring Human Induced Pluripotent Stem Cells
for Substance Abuse Research (R21)
Participating NIH Institute: NIDA
Letter of Intent: February 28, 2011
Receipt date: March 31, 2011, by 5:00 PM local time of applicant
organization.
Purpose: This FOA solicits applications to develop and standardize
methods to generate cell types relevant to substance abuse from human
iPS cells. Cells of interest include neurons and glial cells, and
cells of other tissues, if justification and rationale are provided.
The development of standardized approaches to reprogram or induce
adult cells to become pluripotent stem cells will inform our
understanding of the pathophysiology of substance use and abuse and
may provide a novel mechanism for screening compounds for the
treatment of addiction.
III. PAR-11-099 U.S. - India Bilateral Brain Research Collaborative
Partnerships (U.S. - India BRCP) (R21)
Participating NIH Institutes: NINDS, NIMH and NIDA
Participating Indian Agency: Department of Biotechnology (DBT)
Letter of Intent Due Date: Feb 22, 2011
Application Due date: March 22, 2011
Purpose: The purpose of this program is to support the establishment
and enhancement of bilateral research collaborations between U.S. and
Indian investigators in the field of neuroscience with an emphasis on
understanding, treating and curing neurological, mental and addictive
disorders. Specific areas of research may include, but are not limited
to, studies of mechanisms underlying neurological, mental and
addictive disorders and diseases, planning for population-based
research and clinical trials, the development of infrastructures for
resource, tool and data sharing in addition to projects aimed at
advancing global health research, particularly as it relates to the
mission of the participating organizations.
The National Institute on Drug Abuse at the National Institutes of
Health is an agency of the United States Department of Health and
Human Services
TO UNSUBSCRIBE: send email to list...@list.nih.gov, Copy and paste
UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email
- You will receive a confirmation email if successful. If you have
problems contact jpol...@mail.nih.gov 301-435-1309
http://list.nih.gov/cgi-bin/wa?SUBED1=nida_neuro_science-l&A=1&X=6F4BAE4CF706755A29&Y=nidaneurosc%40mail.nih.gov&A=0
Reply all
Reply to author
Forward
0 new messages